|
First Cohort Complete for Phase 1, Pain Indication IRX211
|
14 June 2023 at 10:25am
|
|
First Patient Dosed for Phase 1, Pain Indication IRX211
|
7 June 2023 at 10:15am
|
|
Constitution
|
6 June 2023 at 5:30pm
|
|
Results of Meeting
|
26 May 2023 at 2:20pm
|
|
AGM Presentation
|
26 May 2023 at 10:40am
|
|
Chairman's Address to Shareholders
|
26 May 2023 at 10:35am
|
|
Quarterly Activities Report
|
28 April 2023 at 4:10pm
|
|
Quarterly Appendix 4C Cash Flow Report
|
28 April 2023 at 4:05pm
|
|
Notice of Annual General Meeting/Proxy Form
|
26 April 2023 at 2:30pm
|
|
Annual Report to shareholders
|
30 March 2023 at 4:10pm
|
|
Appendix 4G & Corporate Governance Statement
|
30 March 2023 at 4:00pm
|
|
Ethics Approval for Phase 1 CRPS
|
21 March 2023 at 10:20am
|
|
Change in substantial holding
|
2 March 2023 at 3:30pm
|
|
Section 708A Notice
|
1 March 2023 at 4:40pm
|
|
Appendix 2A
|
1 March 2023 at 4:40pm
|
|
Preliminary Final Report
|
27 February 2023 at 10:15am
|
|
Results of Meeting
|
17 February 2023 at 3:00pm
|
|
EGM Presentation
|
17 February 2023 at 10:15am
|
|
Chairman's address
|
17 February 2023 at 10:15am
|
|
Notification regarding unquoted securities - IRX
|
13 February 2023 at 9:35am
|
|
Quarterly Activities Report
|
31 January 2023 at 12:05pm
|
|
Quarterly Appendix 4C Cash Flow Report
|
31 January 2023 at 12:05pm
|
|
Ceasing to be a substantial holder
|
23 January 2023 at 9:50am
|
|
Notice of Extraordinary General Meeting/Proxy Form
|
18 January 2023 at 4:35pm
|
|
Contract Research Organisation Appointment
|
22 December 2022 at 9:40am
|
|
Change of Director's Interest Notice
|
16 December 2022 at 2:10pm
|
|
Appendix 3G (Updated)
|
15 December 2022 at 12:35pm
|
|
Appendix 3G
|
15 December 2022 at 10:20am
|
|
FDA Pre-IND Application Update
|
12 December 2022 at 10:20am
|
|
Change in substantial holding
|
14 November 2022 at 10:35am
|
|
Quarterly Activities Report
|
31 October 2022 at 7:35pm
|
|
Quarterly Appendix 4C Cash Flow Report
|
31 October 2022 at 7:30pm
|
|
Change in substantial holding
|
19 October 2022 at 6:10pm
|
|
Section 708A Notice
|
10 October 2022 at 1:45pm
|
|
Initial Director's Interest Notice
|
4 October 2022 at 2:20pm
|
|
Final Director's Interest Notice
|
4 October 2022 at 2:20pm
|
|
Appendix 2A
|
3 October 2022 at 5:40pm
|
|
Appendix 2A
|
3 October 2022 at 5:30pm
|
|
Appendix 3B (updated)
|
3 October 2022 at 5:30pm
|
|
Board and Management Changes
|
27 September 2022 at 10:05am
|
|
Appendix 3B (updated)
|
26 September 2022 at 6:55pm
|
|
Appendix 3B (updated)
|
26 September 2022 at 6:55pm
|
|
Update to Share Placement
|
26 September 2022 at 6:55pm
|
|
Proposed issue of securities - IRX
|
19 September 2022 at 10:35am
|
|
Proposed issue of securities - IRX
|
19 September 2022 at 10:35am
|
|
Private Placement to raise $1.2m
|
19 September 2022 at 10:35am
|
|
Trading Halt
|
15 September 2022 at 9:45am
|
|
Half Yearly Report and Accounts
|
31 August 2022 at 3:30pm
|
|
Quarterly Activities Report
|
28 July 2022 at 4:30pm
|
|
Quarterly Appendix 4C Cash Flow Report
|
28 July 2022 at 4:30pm
|
